Overview
Marden-Walker syndrome (MWS) is an extremely rare congenital disorder characterized by a distinctive combination of fixed facial expression (mask-like facies), blepharophimosis (narrowing of the eye openings), joint contractures, and psychomotor developmental delay. The condition is present from birth and affects multiple body systems, including the musculoskeletal, neurological, and craniofacial systems. Key clinical features include a fixed, immobile facial expression, micrognathia (small jaw), cleft or high-arched palate, low-set ears, and decreased muscle mass. Joint contractures, particularly of the limbs, are a hallmark feature and may limit mobility. Affected individuals frequently exhibit significant intellectual disability and delayed motor milestones. Additional findings may include growth retardation, arachnodactyly (long slender fingers), kyphoscoliosis, and in some cases, renal anomalies or congenital heart defects. Brain abnormalities such as Dandy-Walker malformation or agenesis of the corpus callosum have been reported in some patients. The neurological involvement in Marden-Walker syndrome can be substantial, with many affected individuals showing reduced or absent deep tendon reflexes and generalized hypotonia in infancy that may evolve into hypertonia. Some patients may experience seizures. Connective tissue abnormalities may also be present. The syndrome shares clinical overlap with Schwartz-Jampel syndrome and other conditions involving joint contractures and facial dysmorphism, making careful clinical and genetic evaluation important for accurate diagnosis. There is currently no cure or specific targeted therapy for Marden-Walker syndrome. Treatment is supportive and symptomatic, focusing on physical therapy and orthopedic interventions for joint contractures, developmental support services for intellectual disability, and management of any associated cardiac, renal, or neurological complications. A multidisciplinary approach involving geneticists, neurologists, orthopedic specialists, and developmental pediatricians is recommended. Prognosis varies, but the condition can be associated with significant morbidity, and some cases have been reported with early mortality.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Marden-Walker syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Marden-Walker syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Marden-Walker syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Marden-Walker syndrome.
Community
No community posts yet. Be the first to share your experience with Marden-Walker syndrome.
Start the conversation →Latest news about Marden-Walker syndrome
No recent news articles for Marden-Walker syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Marden-Walker syndrome
What is Marden-Walker syndrome?
Marden-Walker syndrome (MWS) is an extremely rare congenital disorder characterized by a distinctive combination of fixed facial expression (mask-like facies), blepharophimosis (narrowing of the eye openings), joint contractures, and psychomotor developmental delay. The condition is present from birth and affects multiple body systems, including the musculoskeletal, neurological, and craniofacial systems. Key clinical features include a fixed, immobile facial expression, micrognathia (small jaw), cleft or high-arched palate, low-set ears, and decreased muscle mass. Joint contractures, particul
How is Marden-Walker syndrome inherited?
Marden-Walker syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Marden-Walker syndrome typically begin?
Typical onset of Marden-Walker syndrome is neonatal. Age of onset can vary across affected individuals.